Vasopressin for hemorrhagic shock management: Revisiting the potential value in civilian and combat casualty care

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue SUPPL. 1, 2010, Pages

  Voelckel, Wolfgang G ^a   Convertino, Victor A ^b   Lurie, Keith G ^c   Karlbauer, Alois ^a   Schöchl, Herbert ^a   Lindner, Karl Heinz ^d   Trimmel, Helmut ^e  

^a AUVA Trauma Center Salzburg   (Austria)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e General Hospital Wiener Neustadt   (Austria)

Author keywords

Arginine vasopressin; Civilian; Combat; Exsanguination; Hemorrhage; Resuscitation; Shock

Indexed keywords

ARGIPRESSIN; DOPAMINE; NORADRENALIN; HEMOSTATIC AGENT; VASOPRESSIN DERIVATIVE;

BATTLE INJURY; EXCHANGE BLOOD TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART OUTPUT; HEMORRHAGIC SHOCK; HUMAN; HYPOTENSION; MILITARY MEDICINE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; REVIEW; VASOCONSTRICTION; VASOMOTOR REFLEX; COMPLICATION; INJURY SCALE; MASS DISASTER; PROCEDURES; SHOCK, HEMORRHAGIC; SURVIVAL RATE; WAR; WOUNDS AND INJURIES;

HEMOSTATICS; HUMANS; MASS CASUALTY INCIDENTS; RESUSCITATION; SHOCK, HEMORRHAGIC; SURVIVAL RATE; TRAUMA SEVERITY INDICES; VASOPRESSINS; WAR; WOUNDS AND INJURIES;

EID: 85052489023     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181e44937     Document Type: Review

References (42)

1. McManus JG, Eastridge BJ, Wade CE, Holcomb JB. Hemorrhage control research on todays battlefield: lessons applied. J Trauma. 2007;62:S14.
2. Eastridge BJ, Salinas J, McManus JG, et al. Hypotension begins at 110 mm Hg: redefining "hypotension" with data. J Trauma. 2007;63:291- 297; discussion 297-299.
3. Gerhardt R. Impact of emergency medicine specialists in tactical prehospital and en route care: what does the available data say? J Trauma. 2007;62:S11-S12.
4. Butler FK Jr, Holcomb JB, Giebner SD, McSwain NE, Bagian J. Tactical combat casualty care 2007: evolving concepts and battlefield experience. Mil Med. 2007;172:1-19.
5. Yoo JH, Kim MS, Eom KD, Park JI, Park C, Park HM. Vasopressor therapy using vasopressin prior to crystalloid resuscitation in irreversible hemorrhagic shock under isoflurane anesthesia in dogs. J Vet Med Sci. 2007;69:459-464.
6. Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350:105-113. (Pubitemid 38056221)
7. Dunser MW, Westphal M. Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond. Curr Opin Anaesthesiol. 2008;21: 122-127.
8. Dunser MW, Hasibeder WR, Wenzel V. Vasopressin in septic shock. N Engl J Med. 2008;358:2736; author reply 7-8.
9. Dunser MW, Hasibeder WR. Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart! Crit Care. 2006;10:172.
10. Dunser MW, Mayr AJ, Ulmer H, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg. 2001;93: 7-13.
11. Guyton AC. Circulatory shock and physiology of its treatment. In: Guyton AC, ed. Textbook of Medical Physiology. 8th ed. Philadelphia, PA: Saunders; 1991:263-271.
12. Bond RF, Johnson G III. Cardiovascular adrenoreceptor balance during hemorrhagic hypotension and shock. Circ Shock. 1985;16:155-164.
13. Westermann I, Dunser MW, Haas T, et al. Endogenous vasopressin and copeptin response in multiple trauma patients. Shock. 2007;28: 644-649.
14. Errington ML, Rocha ESM Jr. Vasopressin clearance and secretion during hemorrhage in normal dogs and in dogs with experimental diabetes insipidus. J Physiol. 1972;227:395-418.
15. Convertino VA, Sather TM. Vasoactive neuroendocrine responses associated with tolerance to lower body negative pressure in humans. Clin Physiol. 2000;20:177-184.
16. Forrest P. Vasopressin and shock. Anaesth Intensive Care. 2001;29: 463-472.
17. Ericsson BF. Effect of vasopressin on the distribution of cardiac output and organ blood flow in the anesthetized dog. Acta Chir Scand. 1971; 137:729-738.
18. Ericsson BF. Hemodynamic effects of vasopressin. An experimental study in normovolemic and hypovolemic anesthetized dogs. Acta Chir Scand Suppl. 1971;414:1-29.
19. Pieber D, Horina G, Sandner-Kiesling A, Pieber TR, Heinemann A. Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats. Cardiovasc Res. 1999;44:166-175.
20. Brayden JE. Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol. 2002;29:312-316.
21. Salzman AL, Vromen A, Denenberg A, Szabó C. K(ATP)-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock. Am J Physiol. 1997;272:H688-H694.
22. Hierholzer C, Billiar TR. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg. 2001;386:302-308.
23. Cohn SM. Potential benefit of vasopressin in resuscitation of hemorrhagic shock. J Trauma. 2007;62:S56-S57.
24. Robin JK, Oliver JA, Landry DW. Vasopressin deficiency in the syndrome of irreversible shock. J Trauma. 2003;54:S149-S154.
25. Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation. 1999;100:226-229.
26. Raedler C, Voelckel WG, Wenzel V, et al. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesth Analg. 2004;98: 1759-1766.
27. Stadlbauer KH, Wagner-Berger HG, Raedler C, et al. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiol. 2003;98:699-704.
28. Stadlbauer KH, Wenzel V, Wagner-Berger HG, et al. An observational study of vasopressin infusion during uncontrolled haemorrhagic shock in a porcine trauma model: effects on bowel function. Resuscitation. 2007;72:145-148.
29. Voelckel WG, Raedler C, Wenzel V, et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med. 2003;31:1160-1165. (Pubitemid 36444429)
30. Stadlbauer KH, Wagner-Berger HG, Krismer AC, et al. Vasopressin improves survival in a porcine model of abdominal vascular injury. Crit Care. 2007;11:R81.
31. Feinstein AJ, Cohn SM, King DR, Sanui M, Proctor KG. Early vasopressin improves short-term survival after pulmonary contusion. J Trauma. 59:876-882, 2005; discussion 882-883.
32. Sanui M, King DR, Feinstein AJ, Varon AJ, Cohn SM, Proctor KG. Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury. Crit Care Med. 2006;34:433-438.
33. Cavus E, Meybohm P, Doerges V, et al. Cerebral effects of three resuscitation protocols in uncontrolled haemorrhagic shock: a randomised controlled experimental study. Resuscitation. 2009;80:567-572.
34. Yoo JH, Kim MS, Park HM. Hemodynamic characteristics of vasopressin in dogs with severe hemorrhagic shock. J Vet Med Sci. 2006;68: 967-972.
35. Yoo JH, Park C, Hahm DH, Lee HJ, Park HM. Determination of optimal dose of arginine vasopressin in hemorrhagic shock in dogs. J Vet Med Sci. 2007;69:755-758.
36. Voelckel WG, Lurie KG, McKnite S, et al. Comparison of epinephrine with vasopressin on bone marrow blood flow in an animal model of hypovolemic shock and subsequent cardiac arrest. Crit Care Med. 2001;29:1587-1592.
37. Wenzel V, Lindner KH, Augenstein S, et al. Intraosseous vasopressin improves coronary perfusion pressure rapidly during cardiopulmonary resuscitation in pigs. Crit Care Med. 1999;27:1565-1569.
38. Krismer AC, Wenzel V, Voelckel WG, et al. Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a brief analysis of the literature. Anaesthesist. 2005;54:220-224.
39. Haas T, Voelckel WG, Wiedermann F, et al. Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. J Trauma. 2004;57:177-179.
40. Sharma RM, Setlur R. Vasopressin in hemorrhagic shock. Anesth Analg. 2005;101:833-834, table of contents.
41. Lienhart HG, Wenzel V, Braun J, et al. Vasopressin for therapy of persistent traumatic hemorrhagic shock: the VITRIS.at study. Anaesthesist. 2007;56:145-148, 150.
42. Sperry JL, Minei JP, Frankel HL, et al. Early use of vasopressors after injury: caution before constriction. J Trauma. 2008;64:9-14.